Newsroom
Sorted by: Latest
-
Law Offices of Howard G. Smith Encourages Calix, Inc. (CALX) Shareholders To Inquire About Securities Fraud Class Action
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Calix, Inc. (“Calix” or the “Company”) (NYSE: CALX) securities between January 28, 2026 and April 21, 2026, inclusive (the “Class Period”). Calix investors have until July 27, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CALIX, INC. (CALX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE O...
-
Kontron Launches VX30101 High End 3U VPX Board
TOULON, France--(BUSINESS WIRE)--Kontron, a leading global provider of IoT/embedded computer technology (ECT), today announces the upcoming Kontron VX30101. This new-generation 3U VPX High-End Computing Board is designed for AI-enabled mission computing, sensor fusion, rugged embedded servers and tactical edge applications. The ruggedized SWaP-C optimized VX30101 delivers high-performance heterogeneous computing, integrated AI acceleration and ultra-fast networking capabilities. It is among the...
-
AeroVironment, Inc. (AVAV) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AEROVIRONMENT, INC. (AVAV), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal right...
-
Rosen Law Firm Encourages BitGo Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – BTGO
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of BitGo Holdings, Inc. (NYSE: BTGO) resulting from allegations that BitGo may have issued materially misleading business information to the investing public.So What: If you purchased BitGo securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Ro...
-
Bidgely’s EmPOWER AI London Convenes Leaders to Map the Future of Electrification, Load Flexibility, Customer Experience and Energy Affordability
LOS ALTOS, Calif.--(BUSINESS WIRE)--Bidgely is bringing its global insights tour to London from 10-12 June, marking the next vital stop in its premier EmPOWER AI conference series. Part of an international tour spanning Toronto and New York, the London forum serves as an active, collaborative hub for energy retailers ready to lead—rather than react to—rising electrification, critical load flexibility, next-generation customer experience and urgent energy affordability. Through custom workshops...
-
IntegraGen fait un point d’étape sur sa procédure de sauvegarde, tout en poursuivant son recentrage vers les études cliniques biopharma
EVRY, France--(BUSINESS WIRE)--Regulatory News: IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), une société spécialisée dans la génomique du cancer et des maladies génétiques rares, qui réalise des analyses génomiques et de données, interprétables pour des laboratoires académiques et privés, fait aujourd'hui un point d’étape sur sa situation, sur la poursuite de son recentrage stratégique vers les études cliniques biopharma et sur l’évolution envisagée de la procédure de sauvegarde ouvert...
-
ReST Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for RST-101 for the Early Treatment of Post-Traumatic Stress Disorder (PTSD)
PARIS & NEW HAVEN, Conn.--(BUSINESS WIRE)--ReST Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics for stress and trauma-related disorders through precision neuropsychiatry, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for RST-101, its lead investigational therapeutic candidate for the early treatment of post-traumatic stress disorder (PTSD). The IND acceptanc...
-
Medincell: Videoconference and Publication of Annual Financial Results, Tuesday, June 16, 2026
MONTPELLIER, France--(BUSINESS WIRE)--Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing long-acting injectable treatments, today announced the hosting of live videoconference on Tuesday, June 16, 2026, to present its financial results for the fiscal year ending March 31, 2026. The results will be published earlier that day following the closing of the Paris stock exchange. The presentation will be conducted simultaneously in Engli...
-
U-Haul Holding Company to Participate in the Bank of America Self-Storage Virtual Conference
RENO, Nev.--(BUSINESS WIRE)--U-Haul Holding Company (NYSE: UHAL, UHAL.B), parent of U-Haul International, Inc., North America’s largest “do-it-yourself” moving and self-storage company will participate in the Bank of America Self-Storage Virtual Conference on Thursday, May 28, 2026. Jason Berg, Chief Financial Officer, will participate on the Development and Supply Panel at the conference. About U-Haul Holding Company U-Haul Holding Company is the parent company of U-Haul International, Inc., O...
-
Law Offices of Frank R. Cruz Encourages Calix, Inc. (CALX) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Calix, Inc. (CALX) Shareholders To Inquire About Securities Fraud Class Action...